SCHEMBL571073

SCHEMBL571073

CCCCCCCCCC1=C(C)C(=O)c2cc(C)c(C)cc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MAPT P10636 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
THRB P10828 1/20 0.54
ALOX5 P09917 19/20 0.41
MPEG1 Q2M385 7/20 0.41
XIAP P98170 2/20 0.41
GPR84 Q9NQS5 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
PTGES O14684 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571964 1.00 ALDH1A1 (0.54) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571993 1.00 ALDH1A1 (0.54) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571482 1.00 ALDH1A1 (0.54) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571379 1.00 ALDH1A1 (0.54) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571352 1.00 ALDH1A1 (0.54) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571268 0.98 ALDH1A1 (0.51) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL570963 0.93 MAPT (0.45) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571381 0.85 NQO1 (0.38) ALDH1A1MAPTTDP1THRBKDM4E
SCHEMBL571989 0.84 MAPT (0.60) ALDH1A1MAPTTDP1THRBALOX5
SCHEMBL571069 0.84 MAPT (0.60) ALDH1A1MAPTTDP1THRBALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015183985-A2 THERAPEUTIC COMPOSITIONS INCLUDING NAPHTHOQUINONES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
EP-2600857-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES Edison Pharmaceuticals, Inc. (US) 2013-06-12 EP disclosed
WO-2012019029-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES EDISON PHARMACEUTICALS, INC. (US) 2012-02-09 WO disclosed